CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 223542636
- Phone
- 2017502646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- 4 Grant or award Chairman, CEO, President acquired 2,854,279 shares (grant or award)
- 4 Grant or award Director acquired 81,549 shares (grant or award)
- 4 Grant or award CFO, Sec., Treas acquired 122,325 shares (grant or award)
- 4 Grant or award Director acquired 81,549 shares (grant or award)
- 4 Grant or award Director acquired 81,549 shares (grant or award)
- 4 Other acquisition President & CEO acquired 113,954 shares (other)
- 4 Gift Director gave 6,000,000 shares (gift)
- 4 Open-market sale Chairman of Board sold 150,000 shares at an average $0.30 ($45,253)
- 4 Derivatives Options or other derivatives
- 4 Grant or award 10% owner acquired 54,169 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Conversion President & CEO acquired 2,741,801 shares (conversion)
- 4 Conversion Director acquired 2,000,000 shares (conversion)
- 4/A Other acquisition Director acquired 19,275,135 shares (other)
- 4/A Open-market sale Director sold 157,012 shares at $0.41 ($64,626)
- 4/A Other acquisition Director acquired 19,275,135 shares (other)
- 4 Conversion Director acquired 2,000,000 shares (conversion)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Open-market sale Executive VP of Operations sold 85,530 shares at $0.24 ($20,168)
Page 4 of 26 · 511 filings